Saltar al contenido
Immunomodulation Lab
Immunomodulation LabImmunomodulation Lab
  • HOME
  • RESEARCH
  • TEAM
  • PUBLICATIONS
  • FUNDING
  • NEWS
  • CONTACT
Linkedin page opens in new windowX page opens in new window
  • HOME
  • RESEARCH
  • TEAM
  • PUBLICATIONS
  • FUNDING
  • NEWS
  • CONTACT

Categoría: COVID-19

mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals

COVID-19, Publications, Trained ImmunityPor Carlos del Fresnoabril 24, 2023Deja un comentario

We have performed an integral and longitudinal study of the immunological responses triggered by the booster mRNA-1273 vaccination

LogoPubmed

Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study

COVID-19, PublicationsPor Carlos del Fresnomayo 15, 2022Deja un comentario

No abstract available

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19

COVID-19, PublicationsPor Carlos del Fresnoenero 11, 2022Deja un comentario

We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination.

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity

COVID-19, PublicationsPor Carlos del Fresnonoviembre 18, 2021Deja un comentario

COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus.

SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown

COVID-19, PublicationsPor Carlos del Fresnonoviembre 3, 2021Deja un comentario

The Coronavirus Disease of 2019 (COVID-19) pandemic caused by SARS-CoV-2 led the Spanish government to impose a national lockdown in an attempt to control the spread of the infection.

LogoPubmed

The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission

COVID-19, PublicationsPor Carlos del Fresnooctubre 15, 2021Deja un comentario

No abstract available

COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice

COVID-19, PublicationsPor Carlos del Fresnomarzo 7, 2021Deja un comentario

Vaccines against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are urgently needed.

Immunomodulation Lab

Copyright 2025 Artbits All rights reserved. Cookies policy · Privacy policy · Legal Warning

  • Research
  • Publications
  • Contact
Useful Links
Ir a Tienda
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, we'll assume you're ok with it.AcceptNoPrivacy Policy